Executive Briefing · ~9 min read

What Boards Own in CAPEX Approval

A board's role in an industrial capital decision is governance and challenge, not project management. It owns the quality of scrutiny applied at approval and the fiduciary consequences if that scrutiny was inadequate.

Executive summary

The board's role is to test whether the business case has been genuinely challenged before it reaches the table, confirm the assumptions and downside case rather than accept management's summary, ensure approval authority and thresholds are followed rather than bypassed under time pressure, and require periodic reporting against the approved case through execution. The risk that lands on the board is fiduciary — approving a materially flawed case exposes directors to scrutiny from shareholders, lenders or regulators after the fact.

What this role is accountable for

  • A business case reaches the board without evidence of prior internal challenge
  • Approval is being sought under significant time pressure
  • The downside case is thinner than the base case in the board pack
  • Approval thresholds or delegated authority limits are being tested at the margin
  • No mechanism exists for the board to review progress after approval
  • A director has a potential conflict of interest in the proposed supplier or structure

Where the leverage sits

Test the challenge trail

Confirm the case was independently challenged before reaching the board, not only presented by its sponsor.

Interrogate the downside case

Require equal rigour on the downside scenario as on the base case.

Hold approval thresholds

Resist pressure to bypass delegated authority limits for speed.

Set a post-approval reporting cadence

Require defined milestone reporting back to the board, not only at completion.

Declare conflicts explicitly

Ensure any director or executive conflict of interest is disclosed before the vote.

Comparison table

Board scrutiny checklist at approval
CheckEvidence required
Internal challengeRecord of independent review before board submission
Downside caseModelled with comparable rigour to the base case
Authority thresholdsConfirmed within delegated limits, not exception
Conflicts of interestDeclared and managed per governance policy
Post-approval reportingDefined milestone review cadence agreed

Board scrutiny checklist at approval

Risks and governance considerations

  • A board that approves without evidence of internal challenge effectively substitutes for that challenge and carries the resulting exposure
  • Time pressure at approval is a common precursor to inadequate scrutiny
  • Thresholds and delegated authority exist precisely to prevent case-by-case erosion of governance discipline
  • Post-approval silence until completion removes the board's ability to intervene while intervention is still useful
  • Directors should seek independent advice where fiduciary exposure on a specific decision is unclear

What to prepare

  • Evidence of independent internal challenge to the business case
  • A downside scenario modelled to the same standard as the base case
  • Confirmation the decision sits within delegated authority
  • A declared conflicts-of-interest register
  • An agreed post-approval reporting schedule

What to measure

Proportion of CAPEX decisions with documented independent challengePost-approval milestone reporting complianceVariance between board-approved case and outturnTime from board pack circulation to decision

Frequently asked questions

How much technical detail should reach the board?

Enough to test the logic and risk of the decision, summarised by the project owner; full engineering detail belongs at management level, not board level.

What is the board's exposure if a project underperforms after approval?

It depends on jurisdiction and governance framework, but inadequate scrutiny at approval is generally the point of greatest fiduciary exposure, more so than the underperformance itself.

Should the board see the downside case in full?

Yes; approving on the base case alone is a common governance weakness that later scrutiny tends to focus on.

Related investment and financing knowledge

Continue on the platform

Educational, supplier-neutral and financing-neutral

Global B2B Group does not sell equipment and does not represent lenders, export credit agencies or development banks. This material is published to help industrial organisations plan, structure and prepare capital projects. It is general information for decision-making, not financial, legal or tax advice.

Explore the Industrial Investment Center

Home